Literature DB >> 12645003

Molecular mechanisms of S100-target protein interactions.

Danna B Zimmer1, Patti Wright Sadosky, David J Weber.   

Abstract

S100 proteins have no known enzymatic activity and exert their intracellular effects via interaction with and regulation of the activity of other proteins, termed target proteins, in both a Ca(2+)-dependent and Ca(2+)-independent manner. Structural studies have identified the linker region between the two EF-hand Ca(2+) binding domains and the C-terminus as Ca(2+)-dependent target protein binding sites in several S100 family members. In fact, C-terminal aromatic residues are obligatory for interaction of S100A1 with several of its Ca(2+)-dependent target proteins. Pharmacological studies suggest the presence of additional Ca(2+)-dependent binding motifs on some family members. A minimum of seven family members interact with and regulate the activity of aldolase A in a Ca(2+)-independent manner. In the case of S100A1, Ca(2+)-independent target protein interactions utilize a binding motif distinct from the C-terminal Ca(2+)-dependent target protein binding site. Several studies suggest that ionic interactions participate in the interaction of S100 family members with Ca(2+)-independent target proteins. While some target proteins are activated by multiple family members, other target proteins exhibit family member-specific activation, i.e., they are activated by a single family member. As predicted, family member specific interactions appear to be mediated by regions that exhibit the most divergence in amino acid sequence among family members, the linker or "hinge" region and the C terminus. Further specificity in S100-target protein interactions may arise from the different biochemical/biophysical properties of the individual family members, including affinity for metal ions (Ca(2+), Zn(2+), and Cu(2+)), oligomerization properties, heterodimerization, post-translational modifications, and lipid-binding. Delineation of the structural motifs that mediate S100-target protein interactions and determination of the in vivo relevance of these interactions are needed to fully understand the role of S100 proteins in normal and diseased cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645003     DOI: 10.1002/jemt.10297

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  51 in total

1.  S100P is a novel interaction partner and regulator of IQGAP1.

Authors:  Annika Heil; Ali Reza Nazmi; Max Koltzscher; Michaela Poeter; Judith Austermann; Nicole Assard; Jacques Baudier; Kozo Kaibuchi; Volker Gerke
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

2.  The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.

Authors:  Kristin Andersen; Hidetoshi Mori; Jimmie Fata; Jamie Bascom; Tove Oyjord; Gunhild M Mælandsmo; Mina Bissell
Journal:  Dev Biol       Date:  2010-12-31       Impact factor: 3.582

3.  Involvement of the S100B in cAMP-induced cytoskeleton remodeling in astrocytes: a study using TRTK-12 in digitonin-permeabilized cells.

Authors:  Juliana K Frizzo; Ana Carolina Tramontina; Francine Tramontina; Carmem Gottfried; Rodrigo B Leal; Rosario Donato; Carlos-Alberto Gonçalves
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

4.  Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons.

Authors:  Erick O Hernández-Ochoa; Benjamin L Prosser; Nathan T Wright; Minerva Contreras; David J Weber; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

5.  The effect of pentamidine on melanoma ex vivo.

Authors:  Jason Smith; Benjamin J Stewart; Sharon Glaysher; Katharine Peregrin; Louise A Knight; David J Weber; Ian A Cree
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

6.  A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.

Authors:  Sarah C Garrett; Louis Hodgson; Andrew Rybin; Alexei Toutchkine; Klaus M Hahn; David S Lawrence; Anne R Bresnick
Journal:  Biochemistry       Date:  2007-12-23       Impact factor: 3.162

Review 7.  S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.

Authors:  Mirko Völkers; David Rohde; Chelain Goodman; Patrick Most
Journal:  J Biomed Biotechnol       Date:  2010-03-28

Review 8.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

9.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

10.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.